Related Experiment Video
Updated: May 1, 2026

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
Published on: January 18, 2019
Contrast-induced Nephropathy
Nazar M A Mohammed1, Ahmed Mahfouz2, Katafan Achkar3
1Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Insights
Contrast-induced nephropathy (CIN) is a significant cause of acute kidney injury following contrast media procedures. Prevention is key, as current treatments are primarily supportive.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures.
- It is the third most common cause of hospital-acquired acute renal injury, accounting for approximately 12% of cases.
- CIN is defined by a significant rise in serum creatinine post-contrast media administration.
Purpose of the Study:
- To review current evidence on CIN incidence, diagnosis, and prevention.
- To discuss treatment and prognostic implications of CIN.
- To highlight the need for more sensitive renal injury biomarkers.
Main Methods:
- Review of recent scientific literature on contrast-induced nephropathy.
- Analysis of patient- and procedure-related risk factors for CIN.
- Evaluation of diagnostic criteria and emerging biomarkers for renal injury.
Main Results:
- CIN is a frequent complication with significant impact on renal health.
- Multiple patient and procedural factors contribute to CIN development.
- Current treatment is mainly supportive, emphasizing prevention.
Conclusions:
- Prevention strategies are crucial for managing CIN.
- Further research is needed for sensitive biomarkers of tubular injury.
- Understanding risk factors and prognostic implications is vital for patient care.
Abstract:
Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures resulting from the administration of contrast media (CM). It is the third most common cause of hospital acquired acute renal injury and represents about 12% of the cases. CIN is defined as an elevation of serum creatinine (Scr) of more than 25% or ≥0.5 mg/dl (44 μmol/l) from baseline within 48 h. More sensitive markers of renal injury are desired, therefore, several biomarkers of tubular injury are under evaluation. Multiple risk factors may contribute to the development of CIN; these factors are divided into patient- and procedure-related factors. Treatment of CIN is mainly supportive, consisting mainly of careful fluid and electrolyte management, although dialysis may be required in some cases. The available treatment option makes prevention the corner stone of management. This article will review the recent evidence concerning CIN incidence, diagnosis, and prevention strategies as well as its treatment and prognostic implications.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Nephrons
Acute Kidney Injury II: Pathophysiology

